Stevanato Group (STVN) Scheduled to Post Earnings on Thursday

Stevanato Group (NYSE:STVN) is scheduled to be issuing its quarterly earnings data before the market opens on Thursday, May 9th. Analysts expect the company to announce earnings of €0.12 ($0.13) per share for the quarter. Stevanato Group has set its FY 2024 guidance at 0.670-0.710 EPS and its FY24 guidance at €0.62-0.66 EPS.Individual interested in listening to the company’s earnings conference call can do so using this link.

Stevanato Group (NYSE:STVN) last announced its quarterly earnings results on Thursday, March 7th. The company reported €0.18 ($0.19) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of €0.19 ($0.20) by (€0.01) (($0.01)). Stevanato Group had a net margin of 13.43% and a return on equity of 14.31%. The company had revenue of €320.60 million for the quarter, compared to analysts’ expectations of €326.85 million. During the same period in the previous year, the business earned $0.19 EPS. The business’s revenue was up 9.8% compared to the same quarter last year. On average, analysts expect Stevanato Group to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Stevanato Group Trading Up 0.8 %

Shares of Stevanato Group stock opened at €26.67 ($28.68) on Tuesday. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.06 and a current ratio of 1.50. Stevanato Group has a twelve month low of €23.00 ($24.73) and a twelve month high of €36.30 ($39.03). The company’s 50 day moving average is €29.63 and its 200 day moving average is €29.13.

Wall Street Analysts Forecast Growth

Several analysts recently commented on STVN shares. Morgan Stanley reaffirmed an “equal weight” rating and issued a $30.00 price objective on shares of Stevanato Group in a report on Monday, April 22nd. BNP Paribas started coverage on shares of Stevanato Group in a research note on Monday, April 22nd. They issued an “outperform” rating on the stock. Finally, Stephens restated an “overweight” rating and set a $38.00 target price on shares of Stevanato Group in a research report on Monday, March 25th. Two research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of €34.29 ($36.87).

Stevanato Group Company Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.